Abstract
Understanding of the mechanisms of transplant and xenotransplant rejection represents one of the most important aspects of both basic and clinical immunology. This review discusses the roles of 1) immune response and 2) the influence of various products of arachidonic acid metabolism on immune response in graft survival. The review also includes an overview of novel therapeutic approaches developed to prevent, or at least delay, graft rejection. New discoveries in basic and clinical immunology have generated new areas of research in pharmacology that may prevent rejection more efficiently, a key issue in modern medicine.
Keywords: Xenotransplant, transplant, graft rejection, immune response, hyperacute transplant rejection, acute transplant rejection, chronic transplant rejection, arachidonic acid metabolism
Current Pharmaceutical Design
Title: New Frontiers in the Therapeutic Management of Transplant Rejection
Volume: 12 Issue: 19
Author(s): Juan B. De Sanctis, Jenny V. Garmendia, Anna Radzioch and Danuta Radzioch
Affiliation:
Keywords: Xenotransplant, transplant, graft rejection, immune response, hyperacute transplant rejection, acute transplant rejection, chronic transplant rejection, arachidonic acid metabolism
Abstract: Understanding of the mechanisms of transplant and xenotransplant rejection represents one of the most important aspects of both basic and clinical immunology. This review discusses the roles of 1) immune response and 2) the influence of various products of arachidonic acid metabolism on immune response in graft survival. The review also includes an overview of novel therapeutic approaches developed to prevent, or at least delay, graft rejection. New discoveries in basic and clinical immunology have generated new areas of research in pharmacology that may prevent rejection more efficiently, a key issue in modern medicine.
Export Options
About this article
Cite this article as:
De Sanctis B. Juan, Garmendia V. Jenny, Radzioch Anna and Radzioch Danuta, New Frontiers in the Therapeutic Management of Transplant Rejection, Current Pharmaceutical Design 2006; 12 (19) . https://dx.doi.org/10.2174/138161206777698990
DOI https://dx.doi.org/10.2174/138161206777698990 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Dig Deep to Scout the Pharmacological and Clinical Facet of Garlic
(<i>Allium sativum</i>)
Current Traditional Medicine Oxidative Stress and Opioids' Toxicity: An Update
Mini-Reviews in Organic Chemistry Update on Glycoprotein IIb/IIIa: Role in Primary Coronary Intervention
Cardiovascular & Hematological Agents in Medicinal Chemistry Triiodothyronine (T3) Effects on Cardiovascular System in Patients with Heart Failure
Recent Patents on Cardiovascular Drug Discovery Secondary Prevention of Atherothrombotic Cerebrovascular Events
Current Vascular Pharmacology Epigenetic and Disease Targets by Polyphenols
Current Pharmaceutical Design Preface [Hot Topic: Peripheral Arterial Disease (Guest Editors: G. Brevetti / M. Chiariello)]
Current Drug Targets - Cardiovascular & Hematological Disorders Lipoxygenase: An Emerging Target for Stroke Therapy
CNS & Neurological Disorders - Drug Targets Hematopoietic Stem Cells: Transcriptional Regulation, Ex Vivo Expansion and Clinical Application
Current Molecular Medicine Bothrops pauloensis Snake Venom Toxins: The Search for New Therapeutic Models
Current Topics in Medicinal Chemistry Why are People with “Poor Lung Function” At Increased Atherothrombotic Risk?A Critical Review with Potential Therapeutic Indications
Current Vascular Pharmacology Neural Differentiation and Therapeutic Potential of Adipose Tissue Derived Stem Cells
Current Stem Cell Research & Therapy Growing Collateral Arteries On Demand
Recent Patents on Cardiovascular Drug Discovery Measurement of Cerebral Blood Flow with Near Infrared Spectroscopy and Indocyanine Green Dye Dilution
Current Medical Imaging Therapeutic Angiogenesis: Recent and Future Prospects of Gene Therapy in Peripheral Artery Disease
Current Gene Therapy Vascular Endothelium: Functioning in Norm, Changes in Atherosclerosis and Current Dietary Approaches to Improve Endothelial Function
Mini-Reviews in Medicinal Chemistry Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke
CNS & Neurological Disorders - Drug Targets Cardiovascular Pharmacogenetics of Anti-Thrombotic Agents and Non-Steroidal Anti-Inflammatory Drugs
Current Molecular Medicine Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Cord Blood as Diagnostic Window for Preeclampsia
Recent Patents on Biomarkers